✦ LIBER ✦

Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 receptors

✍ Scribed by Yoshihiro Tadori; Robert A. Forbes; Robert D. McQuade; Tetsuro Kikuchi

Book ID: 113589372
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 625 KB
Volume: 666
Category: Article
ISSN: 0014-2999
DOI: 10.1016/j.ejphar.2011.05.050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Functional potencies of new antiparkinso

Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors

✍ Sylvie Perachon; Jean-Charles Schwartz; Pierre Sokoloff 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 180 KB

The dopamine D3 receptor partial agonist

The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors

✍ Karsten Wicke; Javier Garcia-Ladona 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Dopamine D3 -antagonists and partial ago

Dopamine D3 -antagonists and partial agonists

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Evidence for antagonist activity of the

Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor

✍ Martyn D Wood; Izzy Boyfield; David J Nash; Frances R Jewitt; Kim Y Avenell; Gra 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Selectivity of agonists and antagonists

Selectivity of agonists and antagonists at D2dopamine receptors compared to D1 and S2receptors

✍ Dr. Philip Seeman; Dimitri E. Grigoriadis; Hyman B. Niznik 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

Seeman, P., D.E. Grigoriadis, and H.B. Niznik: Selectivity of agonists and antagonists at D2 dopamine receptors compared to D, and S2 receptors. Drug Dev. Res. 9:63-69, ## 1986. The common dopamine agonists (dopamine, apomorphine, ADTN, and N-propylnorapomorphine) are not selective for either D,

P.3.d.001 In-vitro pharmacology of aripi

P.3.d.001 In-vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors

✍ Y. Tadori; A. Forbes; R. McQuade; T. Kikuchi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 96 KB